Latest Us Market Expansion News

Page 1 of 17
Orthocell has secured a strategic foothold in Thailand's $84 million nerve repair sector by appointing MediTime as exclusive Remplir distributor, leveraging established clinical networks to accelerate market penetration.
Ada Torres
Ada Torres
3 July 2026
Cyclopharm Limited delivered a record $17.1 million in revenue for 1H FY26, driven by a 73% surge in US Technegas® sales. However, delays in clinical guideline publication have pushed the short-term US installation target beyond 2026, while medium-term ambitions remain intact.
Ada Torres
Ada Torres
2 July 2026
Smart Parking (ASX:SPZ) has acquired American Parking, adding 54 sites across Oklahoma, Texas, and Arkansas and boosting its US portfolio to over 200 locations. The $12 million deal is expected to be earnings accretive and supports the rollout of SmartCloud technology.
Sophie Babbage
Sophie Babbage
2 July 2026
Jindalee Lithium has completed a A$2.4 million entitlement offer, issuing over 5.2 million shares with attaching options to fund its McDermitt Lithium Project and support a NASDAQ listing.
Maxwell Dee
Maxwell Dee
19 June 2026
LTR Pharma has confirmed it disclosed a binding US commercialisation agreement for ROXUS promptly after signing, responding to ASX scrutiny over pre-announcement trading activity.
Victor Sage
Victor Sage
15 June 2026
Hydralyte USA secures A$392,000 through a share placement, appoints two new non-executive directors, and implements significant cost reductions following CEO resignation as it targets cash-flow break-even and strategic expansion.
Victor Sage
Victor Sage
15 June 2026
Vitrafy Life Sciences has secured A$30 million through an institutional placement to ramp up manufacturing of its Guardion cryopreservation devices and expand US sales operations, with an additional A$2 million sought via a shareholder plan.
Ada Torres
Ada Torres
12 June 2026
Control Bionics advances its neural-signal technology across assistive communication, sports, and medical sectors, securing key US reimbursement and distribution agreements while broadening its international footprint.
Ada Torres
Ada Torres
4 June 2026
Optiscan and Mayo Clinic have completed all key engineering milestones in their two-year partnership to develop a digital endomicroscopic imaging system for robotic surgery, extending their agreement to support further clinical and commercial planning.
Ada Torres
Ada Torres
1 June 2026
4DMedical has landed a three-year commercial contract with SimonMed Imaging, deploying its CT:VQ™ technology across more than 170 US outpatient centres, marking a significant step in its US market expansion.
Ada Torres
Ada Torres
29 May 2026
Bubs Australia expects FY26 revenue between $105 million and $115 million, with underlying EBITDA forecast at $4 million to $8 million despite external challenges including regulatory delays and increased air freight costs.
Victor Sage
Victor Sage
29 May 2026
PainChek has secured A$5.5 million via convertible notes to accelerate its US sales expansion and strengthen working capital amid key commercial milestones.
Ada Torres
Ada Torres
22 May 2026